Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Oncol Clin N Am. 2008 Jul;17(3):467-83, vii. doi: 10.1016/j.soc.2008.02.010.

Recent advances in conventional and molecular prognostic factors for gastric carcinoma.

Author information

1
Surgery Branch, Department of Oncological and Surgical Sciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy. donato.nitti@unipd.it

Abstract

Despite radical surgery, the prognosis of patients who have gastric carcinoma remains unsatisfactory because of the intrinsic but unpredictable aggressiveness of this malignancy. During the past decade an ever-growing list of molecular prognostic factors has been proposed based on the discovery of the mechanisms underlying gastric cancer aggressiveness. Studies performed in larger and more homogeneous series of patients and adequate statistical analysis are warranted before any of the candidate biomarkers can be implemented in the routine clinical setting for the identification of patients at higher risk and thus for the selection of candidates for adjuvant or more aggressive therapies.

PMID:
18486878
DOI:
10.1016/j.soc.2008.02.010
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center